Abstract:Tumor necrosis factor α (TNF-α) is a cytokine that plays a major role in several chronic inflammatory disorders. Anti-TNF-α therapy has been widely employed in clinic. However, the source of natural human TNF-α is so limited that it's difficult to meet the research needs. The purpose of this project is to construct an effective prokaryotic expression system for recombinant human TNF α (rhTNF-α). The sequence of hTNF-α is retrieved from Entrez Gene at NCBI. The whole gene of hTNF-α is optimized, synthezied by a company, inserted into the expression vector pET-28a (+) and expressed in E. coli BL21 (DE3). The N-terminus of hTNF-α contains a His-tag and a TEV protease site. The 10 ×His-tag is used to purify the protein by Ni+-NTA, and the TEV protease site is used to remove the His-tag. The soluble expression conditions of hTNF-α were optimized by orthogonal array design. The large-scale fermentation was carried out under optimized conditions. The expressed rhTNF-α protein was purified by Ni+ affinity chromatography. Then, the 10 ×His tag was removed by TEV protease treatment and followed though Ni+ column again. The purification effect was identified by SDS-PAGE and western blot. The biological activity of rhTNF-α was evaluated by MTT method with L929 cells as target cells. The recombinant cloning and expressing plasmid of rhTNF-α was successfully constructed. The outflow from the Ni column was the purified rhTNF-α, showing single polypeptide band by SDS-PAGE. The productivity of purified rhTNF-α is about 4.17 mg/L. L929 cell cytotoxicity assay showed IC50<10 ng/mL. An effective prokaryotic expression system for rhTNF-α was successfully constructed in our study. The application of two-step Ni+ affinity chromatography purification method could produce soluble rhTNF-α protein with high purity and relative bioactivity.

Construction,expression and cytotoxicity of mutant R31L TNF-α

Construction of Recombined Plasmids of TNFR1 and Its Mutants and Their Tumor Bio-functions

Construction and function research of catalytic site deleted transmembrane TNF-α mutants

Effect of TNF-α rs1800620 and rs4645843 on the Content of TNF-α in LX-2 Cell Line

Construction of eukaryotic recombinant sTNFR1 plasmid and its inhibitory effects on TNF-α cytotoxicity in vitro

Study of Prokaryotic Expression and Biological Activity of Homo sapiens Kras Protein

Applying a New PCR Method to Quickly Prepare Human TNF-α Deletion Mutants

[Study on the Preliminary Purification and Bioactivity of Recombinant Human TNF-alpha Mutein 471].

Leader sequence is required for activity of transmembrane tumor necrosis factor-α

A Single Codon Optimization Enhances Recombinant Human TNF-α Vaccine Expression in Escherichia Coli

Deletions of Different Region of Human Transmembrane Tumor Necrosis Factor (Tm-Tnf-α) Signal Peptide and Cytotoxic Activity

Biological Activities of Human Tumor Necrosis Factor-Alpha and Its Novel Mutants.

Expression and Purification of Recombinant Human Tumor Necrosis Factor α in Escherichia Coli

Antitumor Effects of the Fibroblasts Transfected TNF-α Gene and Its Mutants

Function of 87~(th) Position Amino Acid Residue in Target Cell Apoptosis Induced by TM-TNF-#alpha#

A single nucleotide mutation drastically increases the expression of tumor-homing NGR-TNFα in the E. coli M15-pQE30 system by improving gene transcription

Prokaryotic Expression of Human sTNFR1 Gene and the Anti-apoptosis Activity of its Recombinant Protein

Construction and Biological Assay of Human Interferon Α1 B Mutant 31 K

Construction, Expression, and Bio-Activity Assay of an Anti-Il-1βscfv and TNFR1 Fusion Protein

Construction of a Recombinant Eukaryotic Vector Expressing Human Tumor Necrosis Factor Alpha

Construction of Eukaryotic Expression Vector of Wild-type/Transmembrane TNF and The Effect on Cardiomyocyte Apoptosis